Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

Methods of Medium Optimization

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine·2026

Same author

Optimal designs for discrete-time survival models with competing risks.

Lifetime data analysis·2026

Same author

Correction: Randomization in the age of platform trials: unexplored challenges and some potential solutions.

BMC medical research methodology·2026

Same author

Two-level non-regular fractional factorial designs for public health studies.

BMC medical research methodology·2026

Same author

Estimands for long-term follow-up trials in gene therapy products.

Journal of biopharmaceutical statistics·2025

Same author

Randomization in the age of platform trials: unexplored challenges and some potential solutions.

BMC medical research methodology·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Optimal response-adaptive randomized designs for multi-armed survival trials.

Oleksandr Sverdlov¹, Yevgen Tymofyeyev, Weng Kee Wong

¹Bristol-Myers Squibb, Route 206 and Province Line Road, Princeton, NJ 08543, USA. alex.sverdlov@bms.com

Statistics in Medicine

|August 9, 2011

Summary

Optimal adaptive designs for multi-arm survival trials improve treatment effect precision and minimize sample size. These novel designs are more efficient and ethical than traditional balanced approaches, enhancing clinical trial methodology.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 30, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

Biostatistics
Clinical Trial Design
Survival Analysis

Background:

Traditional clinical trials often use balanced designs, which may not be optimal for multiple treatment arms in survival studies.
Adaptive allocation strategies can improve efficiency and ethical considerations in clinical trial design.

Purpose of the Study:

To propose and evaluate optimal adaptive designs for multi-arm survival intervention trials.
To compare the performance of proposed optimal designs against balanced designs using theoretical analysis and simulations.

Main Methods:

Utilized optimal design theory to develop three adaptive allocation strategies for multi-arm survival trials.
Designs focused on maximizing treatment effect precision, minimizing sample size, and reducing total cohort hazard.
Compared operating characteristics, including robustness to model misspecification, via theoretical analysis and simulation.

Main Results:

Proposed optimal designs are frequently unbalanced, deviating from traditional balanced allocation ratios.
Optimal designs demonstrated superior efficiency and ethical advantages compared to balanced designs.
Application to a head and neck cancer trial showed the practical utility of the response-adaptive strategy.

Conclusions:

Optimal adaptive designs offer significant improvements in efficiency and ethical conduct for multi-arm survival trials.
These novel designs provide a more precise and resource-conscious approach to clinical trial methodology.
The findings support the adoption of optimal adaptive strategies in future survival intervention studies.